Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Brueggemann · SciRah

Researcher profile · Semantic Scholar

M. Brueggemann

Share profile

M. Brueggemann — researcher profile on SciRah

h-index: 9
Works: 26
Citations: 422

Most-cited papers

Immunochemotherapy with Rituximab Improves Molecular CR Rate and Outcome In CD20+ B-Lineage Standard and High Risk Patients; Results of 263 CD20+ Patients Studied Prospectively In GMALL Study 07/2003
D. Hoelzer, A. Huettmann, F. Kaul, S. Irmer +10 more
201086 citations
Semantic Scholar
Moderate Intensive Chemotherapy Including CNS-Prophylaxis with Liposomal Cytarabine Is Feasible and effective in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Trial From the German Multicenter Study Group for Adult ALL (GMALL)
N. Goekbuget, J. Beck, M. Brueggemann, T. Burmeister +14 more
201269 citations
Semantic Scholar
PEG-Asparaginase Intensification In Adult Acute Lymphoblastic Leukemia (ALL): Significant Improvement of Outcome with Moderate Increase of Liver Toxicity In the German Multicenter Study Group for Adult ALL (GMALL) Study 07/2003
N. Goekbuget, Anja Baumann, J. Beck, M. Brueggemann +14 more
201056 citations
Semantic Scholar
Anti-CD19 BiTE Blinatumomab Induces High Complete Remission Rate and Prolongs Overall Survival in Adult Patients with Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL)
M. Topp, N. Goekbuget, G. Zugmaier, A. Viardot +13 more
201249 citations
Semantic Scholar
Anti-CD19 BiTE Blinatumomab Induces High Complete Remission Rate In Adult Patients with Relapsed B-Precursor ALL: Updated Results of An Ongoing Phase II Trial
M. Topp, N. Goekbuget, G. Zugmaier, A. Viardot +13 more
201139 citations
Semantic Scholar
PEG-Asparaginase in Adult Acute Lymphoblastic Leukemia (ALL): Efficacy and Feasibility Analysis with Increasing Dose Levels
N. Goekbuget, Anja Baumann, J. Beck, J. Boos +14 more
200825 citations
Semantic Scholar
The Interlaboratory Robustness Of Next-Generation Sequencing (IRON) Study Phase II: Deep-Sequencing Analyses Of Hematological Malignancies Performed In 8,867 Cases By An International Network Involving 27 Laboratories
A. Kohlmann, G. Martinelli, W. Hofmann, G. Kronnie +24 more
201219 citations
Semantic Scholar
New Definition of Treatment Response in Adult Acute Lymphoblastic Leukemia (ALL): Use of Molecular Markers for Minimal Residual Disease (MRD).
N. Goekbuget, M. Brueggemann, R. Arnold, C. Bartram +12 more
200914 citations
Semantic Scholar
Long-term survival of adults with B-cell precursor (BCP) acute lymphoblastic leukemia (ALL) after treatment with blinatumomab and subsequent allogeneic hematopoietic stem cell transplantation (HSCT).
M. Topp, A. Stein, G. Zugmaier, H. Dombret +6 more
201810 citations
Semantic Scholar
Final Induction Therapy Results of an Open Label Phase II Study Using Inotuzumab Ozogamicin for Induction Therapy, Followed By a Conventional Chemotherapy Based Consolidation and Maintenance Therapy in Patients Aged 56 Years and Older with Acute B-Lymphoblastic Leukemia (INITIAL-1 trial)
M. Stelljes, N. Alakel, R. Wäsch, Sebastian Scholl +17 more
2021Blood9 citations Open access
Semantic Scholar
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus elotuzumab and KRd in transplant-eligible patients with newly diagnosed multiple myeloma: Post-induction response and MRD results from an open-label randomized phase 3 study.
S. Knop, Thomas Stuebig, M. Kull, R. Greil +16 more
2023Journal of Clinical Oncology8 citations
Semantic Scholar
Treatment and outcome of IG-MYC+ neoplasms with precursor B-cell phenotype in childhood and adolescence
Heidi Herbrueggen, S. Mueller, Jonas Rohde, Laura Arias Padilla +12 more
2019Leukemia8 citations
Semantic Scholar
Long-Term Survival in Adult Patients with Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL) Who Achieved Minimal Residual Disease (MRD) Response Following Anti-CD19 BiTE® Blinatumomab
G. Zugmaier, N. Goekbuget, A. Viardot, M. Stelljes +13 more
20147 citations
Semantic Scholar
CD19/CD3 Bispecific Antibody Blinatumomab (MT-103) Is Highly Effective In Treatment of Patients with Minimal Residual Disease From Chemotherapy-Resistant B-Precursor Acute Lymphoblastic Leukemia
M. Topp, G. Zugmaier, N. Goekbuget, S. Neumann +21 more
20107 citations
Semantic Scholar
Update on GMALL Trial 08/2013 Shows Durable Favorable Outcome of Newly Diagnosed Adult Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL) with Imatinib, Dose-Reduced Induction Followed By Stem Cell Transplantation
H. Pfeifer, F. Lang, Walter Fiedler, M. Stelljes +15 more
2024Blood6 citations
Semantic Scholar
Venetoclax and Blinatumomab for Adult Patients with Relapsed/Refractory or MRD Positive Ph-Negative B-Precursor ALL: First Results of the GMALL-Bliven Trial
L. Fransecky, Walter Fiedler, C. Röllig, T. Sauer +14 more
2023Blood6 citations Open access
Semantic Scholar
Quantitative Assessment of Circulating t(14;18) Positive Cells by RQ-PCR at Diagnosis and Follow-Up Correspond to Clinical Characteristics and Predicts Time to Treatment Failure in Follicular Lymphoma.
C. Pott, S. Boettcher, M. Brueggemann, T. Raff +6 more
20063 citations
Semantic Scholar
Next-Generation Dendritic Cell Vaccination in Postremission Therapy of AML: Results of a Clinical Phase I Trial
K. Deiser, F. Lichtenegger, Frauke M. Schnorfeil, Thomas Koehnke +9 more
20151 citations
Semantic Scholar
Implicit reconstruction of gating strategies from sample-level flow cytometry annotations
M. Buser, M. Szczepanowski, A. Laqua, G. Chitadze +3 more
2026medRxiv0 citations Open access
Semantic Scholar
Non-Functional (haploinsufficient), but Not Dominant Negative Clonal IKZF1 Deletions Confer an Adverse Prognosis in Adult BCR-ABL-Negative Acute Lymphoblastic Leukemia
B. Kobitzsch, N. Gokbuget, S. Schwartz, R. Reinhardt +7 more
20150 citations
Semantic Scholar
T-Prolymphocytic Leukemia Is Sensitive to Polyclonal T Cell-Derived Graft-Versus-Leukemia Effects: Evidence from Minimal Residual Disease Kinetics and TCR Repertoire Diversity Analyses
L. Sellner, P. Dreger, M. Schlitt, H. Knecht +11 more
20150 citations
Semantic Scholar
Clonal Architectures Of Bcr-Abl Plus Bcp-All: Implications For Anti B-Cell Directed Therapy
M. Bartels, I. Nagel, S. Ussat, O. Ottmann +8 more
20150 citations
Semantic Scholar
Single Nucleotide Polymorphisms in IKZF1, ARID5B and CEBPE are a Risk Factor for the Development of Adult ALL
T. Burmeister, Gesine Bartels, Daniel Groeger, H. Trautmann +11 more
20140 citations
Semantic Scholar
Exome Sequencing Identifies Recurring DNMT3A Mutations in Adult ETP-ALL
M. Neumann, S. Heesch, C. Schlee, S. Schwartz +13 more
20120 citations
Semantic Scholar
Overall Outcome of Relapsed Acute Lymphoblastic Leukemia Can Be Improved by Stem Cell Transplantation and Early Treatment in Stage of Molecular Relapse
N. Goekbuget, Daniel Stanze, R. Arnold, M. Brueggemann +11 more
20110 citations
Semantic Scholar
Emergence of Dominant T-Cell Populations in Patients with CLL after Allogeneic Transplantation: Mediators for Gvl Effects?
M. Ritgen, M. Brueggemann, S. Boettcher, T. Raff +4 more
20080 citations
Semantic Scholar
Primers for nucleic acid amplification in pcr-based klonalitätsstudien
Dongen Jacobus Johannes Van, A. Langerak, E. Schuuring, Miquel Jesus Fernando San +12 more
20030 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Goekbuget×16
Invite
N. Goekbuget — researcher profile on SciRah
D. Hoelzer×11
Invite
D. Hoelzer — researcher profile on SciRah
M. Kneba×10
Invite
M. Kneba — researcher profile on SciRah
A. Viardot×8
Invite
A. Viardot — researcher profile on SciRah

×7

Invite

M. Stelljes — researcher profile on SciRah

Invite

A. Reichle — researcher profile on SciRah

Invite

T. Raff — researcher profile on SciRah

Invite

M. Topp — researcher profile on SciRah

Invite

G. Zugmaier — researcher profile on SciRah

Invite

H. Horst — researcher profile on SciRah

Invite

H. Einsele — researcher profile on SciRah

Invite

R. Bargou — researcher profile on SciRah